Riogin
RioGin is an early stage biotechnology company, based in Charlottesville VA, born from a collaboration between Geysen Enterprises.
Business Model:
Revenue: $0
Employees: 1-10
Rankings
Industries / Tags:
Detailed Riogin Information
Geographic Data
Address:
City: Charlottesville
State: Virginia
Zip:
Country: United States
Financial Info
Stage:
seed
Raised Last:
$0
Raised Total:$0
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
RioGin is an early stage biotechnology company, based in Charlottesville VA, born from a collaboration between Geysen Enterprises and SRI International. RioGin is dedicated to improving the pharmacokinetic properties of peptide drugs without negatively impacting their pharmacodynamic properties. Using their proprietary platform technology, RioGin is advancing patient quality of life through convenient dosing and reduced side effects resulting in better compliance. For their pharma partners RioGin extends patent life, protecting and expanding existing franchises and enables more efficacious drug therapies. They believe with RioGin&s;s platform technology peptide drugs will be able to fully reach their potential and gain their true place in the everyday therapeutic arsenal.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 4/2014 | Seed Round | 1 | - |
Virginia Venture Partners Virginia Venture Partners |
4/2014 | Seed Round | 1 | - |
Virginia Venture Partners Virginia Venture Partners |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
